Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma

World Journal of Gastroenterology

Volumn 16, Issue 3, 2010, Pages 339-344

  Zheng, Yao ^a   Wang, Lin ^a   Zhang, Jian Ping ^a   Yang, Jing Yan ^a   Zhao, Zhu Mei ^a   Zhang, Xiao Ying ^a  

^a NONE

Author keywords

Atypical intestinal metaplasia; c erbB 2; Ki67; p53; Simple intestinal metaplasia

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; ATYPICAL INTESTINAL METAPLASIA; CANCER STAGING; CANCER SURGERY; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; GASTRECTOMY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; PROTEIN EXPRESSION; SIMPLE INTESTINAL METAPLASIA; STOMACH CARCINOMA; TISSUE SECTION;

EID: 75349105946     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i3.339     Document Type: Article

References (30)

1. Cahill RJ, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996; 38: 177-181
2. Matsukuma A, Mori M, Enjoji M. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 1990; 66: 689-694
3. Heilmann KL, Höpker WW. Loss of differentiation in intestinal metaplasia in cancerous stomachs. A comparative morphologic study. Pathol Res Pract 1979; 164: 249-258
4. Teglbjaerg PS, Nielsen HO. "Small intestinal type" and "colonic type" intestinal metaplasia of the human stomach, and their relationship to the histogenetic types of gastric adenocarcinoma. Acta Pathol Microbiol Scand A 1978; 86A: 351-355
5. Sipponen P, Seppälä K, Varis K, Hjelt L, Ihamäki T, Kekki M, Siurala M. Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A 1980; 88: 217-224
6. Rothery GA, Day DW. Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa. J Clin Pathol 1985; 38: 613-621
7. Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J 1981; 13: 931-939
8. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 1979; 3: 191-199
9. Wittekind C, Klimpfinger M, Hermanek P, Tannapfel A. Multiple simultaneous gastric carcinomas. Br J Cancer 1997; 76: 1604-1609
10. Burkitt MD, Varro A, Pritchard DM. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 2009; 15: 1-16
11. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 5 Suppl 1: 5-11
12. Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL, Zhang X. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol 2004; 10: 804-808
13. Rivera F, Vega-Villegas ME, López-Brea MF. Chemotherapy of advanced gastric cancer. Cancer Treat Rev 2007; 33: 315-324
14. Wang CH, Yu YZ. Research progress on intestinal metaplasia of the gastric mucosa. Zhongguo Shiyong Neike Zazhi 2004; 9: 562-564
15. Whitehead R, Skinner JM, Heenan PJ. Incidence of carcinoma of stomach and tumour type. Br J Cancer 1974; 30: 370-372
16. Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955; 9: 377-385
17. Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986; 10: 1271-1277
18. McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 1986; 83: 130-134
19. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093
20. Harris AL. Mutant p53 - the commonest genetic abnormality in human cancer? J Pathol 1990; 162: 5-6
21. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 511-517
22. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 1986; 319: 230-234
23. Tal M, Wetzler M, Josefberg Z, Deutch A, Gutman M, Assaf D, Kris R, Shiloh Y, Givol D, Schlessinger J. Sporadic amplification of the HER2/ neu protooncogene in adenocarcinomas of various tissues. Cancer Res 1988; 48: 1517-1520
24. Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res 1989; 49: 6605-6609
25. Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, Matsumoto Y, Fujino MA, Ooi A. Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. Int J Cancer 2002; 98: 833-837
26. Ooi A, Kobayashi M, Mai M, Nakanishi I. Amplification of c-erbB-2 in gastric cancer: detection in formalinfixed, paraffin-embedded tissue by fluorescence in situ hybridization. Lab Invest 1998; 78: 345-351
27. Dursun A, Poyraz A, Celik B, Akyol G. Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67. Pathol Oncol Res 1999; 5: 104-106
28. Mueller J, Werner M, Siewert JR. Malignant progression in Barrett's esophagus: pathology and molecular biology. Recent Results Cancer Res 2000; 155: 29-41
29. Yu CC, Woods AL, Levison DA. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 1992; 24: 121-131
30. Forones NM, Carvalho AP, Giannotti-Filho O, Lourenço LG, Oshima CT. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq Gastroenterol 2005; 42: 30-34